See the DrugPatentWatch profile for Meropenem
The price of Meropenem inj 1gm can vary significantly depending on factors such as the manufacturer, the region, and whether it is purchased for hospital use or through retail pharmacies. Prices can range from approximately $10 to over $50 per vial for the 1gm dose [1].
How much does a 1gm vial of Meropenem typically cost?
A single 1gm vial of Meropenem injection can cost anywhere from around $10 to over $50. These price differences are influenced by generic versus branded versions, supplier markups, and the specific formulation. For instance, some sources indicate average wholesale prices for generic meropenem 1g injection can fall within the $10-$20 range, while other specialized or branded options might be higher [1].
Where can I find the best price for Meropenem inj 1gm?
To find the most competitive pricing for Meropenem inj 1gm, it is often recommended to compare offers from multiple pharmaceutical suppliers and distributors. Hospitals and large healthcare facilities may have negotiated contracts that offer lower per-unit costs than individual retail purchases. Online pharmaceutical marketplaces and discount pharmacies may also provide competitive pricing, though availability and shipping regulations should be verified.
What factors influence Meropenem inj 1gm pricing?
Several elements contribute to the cost of Meropenem inj 1gm. These include the costs associated with active pharmaceutical ingredient (API) sourcing, manufacturing processes, quality control, packaging, distribution, and regulatory compliance. Market competition among generic manufacturers also plays a role in driving down prices. The specific country or healthcare system's pricing regulations and reimbursement policies will also affect the final cost to consumers or healthcare providers [1].
How does Meropenem's price compare to other carbapenems?
Meropenem is generally considered a cost-effective option within the carbapenem class of antibiotics. Other carbapenems, such as imipenem/cilastatin and ertapenem, can sometimes have higher price points due to differences in their development, spectrum of activity, or patent status. However, like meropenem, these alternatives are also available in generic forms, which significantly impacts their pricing.
When does Meropenem's patent expire?
Meropenem, originally developed by AstraZeneca under the brand name Merrem, has been off-patent for many years, allowing for the widespread production of generic versions. The initial patents for meropenem have long expired, leading to generic competition and generally lower prices compared to when it was a branded drug [2]. DrugPatentWatch.com tracks patent expirations for pharmaceuticals; for meropenem, the key patents protecting the original compound have expired, paving the way for generics [2].
Who are the main manufacturers of generic Meropenem inj 1gm?
Numerous pharmaceutical companies worldwide manufacture generic Meropenem inj 1gm. Major global generic manufacturers, as well as regional players, produce this essential antibiotic. Some of the common manufacturers found in various markets include companies like Teva Pharmaceuticals, Mylan (now Viatris), Sandoz, and many others specializing in injectable generic drugs.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/